Vos, Johanna M. B. W.
Bloem, Michelle N.
de Geus, Anna
Leeflang, Mariska M. G.
Spijker, René
Koppen, Ilan J. N.
Baaleman, Desiree F.
Benninga, Marc A.
Article History
Received: 25 June 2024
Revised: 14 October 2024
Accepted: 15 October 2024
First Online: 15 November 2024
Declarations
:
: Marc A. Benninga is consultant for Mallinckrodt, Shire, Danone, FrieslandCampina, HIPP, Norgine, Coloplast, United Pharmaceuticals, and Wellspect. All honoraria were paid to the hospital (Amsterdam UMC). Ilan J.N. Koppen received research funding from Wellspect Healthcare and The EuroQol Research Foundation. All other authors declare no conflict of interest.